Lv11
40 积分 2024-10-25 加入
TP53 Mutations in Human Cancers: Origins, Consequences, and Clinical Use
43分钟前
已关闭
Heterogeneity of TP53 Mutations and P53 Protein Residual Function in Cancer: Does It Matter?
1小时前
已关闭
Modified Podophyllotoxin Phenoxyacetamide Phenylacetate Derivatives: Tubulin/AKT1 Dual-Targeting and Potential Anticancer Agents for Human NSCLC
1小时前
已完结
Interplay between Signaling Pathways and Tumor Microenvironment Components: A Paradoxical Role in Colorectal Cancer
4天前
已完结
EP.12A.24 Prognostic Value of Functional Subtype Classification of Co-Occurring TP53 Mutations in Patients with EGFR-Mutant NSCLC Treated with TKI
4天前
已关闭
Signal Pathways in Cancer
4天前
已完结
Double-headed molecule activates cell-death pathways in cancer cells
4天前
已完结
To Reveal the Potential Mechanism of Quercetin against NSCLC Based on Network Pharmacology and Experimental Validation
5天前
已完结
Quercetin acts as a novel anti-cancer drug to suppress cancer aggressiveness and cisplatin-resistance in nasopharyngeal carcinoma (NPC) through regulating the yes-associated protein/Hippo signaling pathway
5天前
已完结
Large-scale screening for somatic mutations in lung cancer
6天前
已完结
皖公网安备34019202002308
